Reckitt Benckiser Group (LON:RKT – Get Free Report) was downgraded by investment analysts at Royal Bank Of Canada to a “sector perform” rating in a research report issued on Wednesday, Marketbeat reports. They presently have a GBX 6,200 price objective on the stock, down from their prior price objective of GBX 6,400. Royal Bank Of Canada’s price objective would indicate a potential upside of 0.88% from the stock’s current price.
A number of other research analysts also recently weighed in on RKT. Deutsche Bank Aktiengesellschaft raised their price objective on Reckitt Benckiser Group from GBX 5,600 to GBX 5,700 and gave the company a “buy” rating in a research note on Friday, October 24th. JPMorgan Chase & Co. lifted their price target on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 6,100 and gave the company a “neutral” rating in a research report on Wednesday, November 26th. UBS Group restated a “buy” rating and issued a GBX 7,700 price objective on shares of Reckitt Benckiser Group in a research note on Friday, October 17th. Finally, Jefferies Financial Group upped their price objective on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 5,700 and gave the stock a “hold” rating in a report on Wednesday, January 7th. Three research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of GBX 6,279.29.
View Our Latest Research Report on RKT
Reckitt Benckiser Group Trading Down 0.6%
Insider Buying and Selling
In related news, insider Patricia Verduin purchased 135 shares of Reckitt Benckiser Group stock in a transaction on Wednesday, October 29th. The stock was purchased at an average cost of GBX 5,867 per share, with a total value of £7,920.45. 0.42% of the stock is currently owned by insiders.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Recommended Stories
- Five stocks we like better than Reckitt Benckiser Group
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Look who’s buying 2 tonnes of gold… per week!
- Virtually Unknown AI Company Solving Trillion-Dollar Problem
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
